therapeutics update tramadol j falk
TRANSCRIPT
IS THIS SEAT TAKEN?A Review of TRAMADOL in Pain Management
Jamie Falk, PharmD
MCFP Annual Scientific Assembly
April 22, 2010
Common Questions
How does tramadol work? Which patients might it benefit? Is it better tolerated than other analgesics? Does it have abuse potential? Where does it fit in the analgesic continuum?
How does it work?
Weak -opioid receptor effects Structurally related to morphine and codeine
~10-fold less affinity for receptor than codeine and up to 6000-fold less than morphine
Metabolized to highly active M1 300-fold greater affinity than parent compound
Analgesia only partially blocked by naloxone (~33%)
Serotonin and norepinephrine reuptake inhibition Effect reduced by > ½ by adrenergic receptor antagonist Less than that with imipramine
Grond S, et al. Clin Pharmacokin 2004;43:879-923.Raffa RB. J Clin Pharm Therap 2008;33:101-8.
Kinetic/Dynamic Specs
Onset of action: ~ 30 minutes
Peak action: 2 – 3 hours
Duration of action: 4 – 6 hours
Extensive hepatic metabolism Metabolized to M1 by CYP2D6 Dose reduction required for cirrhosis
Urinary elimination 30% as unchanged; 60% of M1 excreted Dose reduction required for severe renal impairment
Grond S, et al. Clin Pharmacokin 2004;43:879-923.
Efficacy Acute Pain
Chronic Pain Osteoarthritis Neuropathic Pain Low back pain
Acute Pain
Many small studies vs. opioids Likley = morphine in equi-analgesic doses (T:M = ~10:1)
up to 400 – 600mg/day maximum NNT (50% reduction in pain vs. placebo)
= 4.8 for tramadol 100mg= 3.6 for codeine 60mg + ASA
Many small studies vs. non-opioids Similar analgesia compared to NSAIDs post-operatively in
a variety of doses
Grond S, et al. Clin Pharmacokin 2004;43:879-923.
Osteoarthritis
Cochrane Review of Tramadol in OA 11 RCTs (n=1939 with symptomatic OA of knee or hip)
Tramadol (+/- acetaminophen) vs. placebo (6 studies), or active control (5 studies – acetaminophen,
diclofenac, dihydrocodeine, propoxyphene, pentazocine) average n = 108
Mean daily tramadol dose = 201.4mg +/- 50.15 Average length of f/u = 35 days
Active control (non-placebo) = 17 days
Cepeda MS, et al. CDSR 2009.
Osteoarthritis
Intervention Δ Pain
intensity (0-100)
Δ Functional improvement (WOMAC 0-10)
Global improvement
(NNT for reporting moderate
improvement)Tramadol vs. placebo -8.5 -0.34 6
Cepeda MS, et al. CDSR 2009.
Intervention Minor adverse
event (NNH)
Major adverse
events (NNH)Tramadol vs. placebo 5 8
Most common AEs:Nausea, vomiting,dizziness, constipation,somnolence, tiredness,headache
Separate MAs:NSAID Δ = -10Opioid Δ = -9
Acetaminophen Δ =-4
Separate MA:Acetaminophen NNT =
6 Separate MA:
Opioid Δ = -0.7Separate MA:Opioid NNH = 12
Separate MA:Opioid NNH = 19
Chronic Low Back Pain
Insufficient evidence available to compare tramadol to traditional opioids
Two parallel studies comparing celecoxib to tramadol
Cochrane Review of Opioids in Chronic LBP 3 RCTs (n=914)
Tramadol vs. placebo (3 studies) Mean tramadol dose = 150 – 240mg/day Duration of f/u = 4 wks – 3 months
Chou R, et al. Ann Intern Med 2007;147:505-14.O’Donnell JD, et al. J Int Med Res 2009;37:1789-1802.Deshpande A, et al. CDSR 2008.
Chronic Low Back Pain
Intervention Δ Pain intensity (0-100)
Δ Functional Improvement
(RDQ 0-24 )Tramadol vs. placebo -10.8 -1.0
Adverse events
RD (%)
nausea 9%somnolence 9%dizziness 8%constipation 8%
dry mouth 7%headache 3%
Intervention 30% Pain Improvemen
t (%)
Withdrawal due to
tolerability (%)
Tramadol 50mg QID 52 13.4
celecoxib 200mg BID 63 10.6* all differences statistically significant
Deshpande A, et al. CDSR 2008.O’Donnell JD, et al. J Int Med Res 2009;37:1789-1802.
Neuropathic Pain
Canadian Pain Society Guidelines (2007) Tramadol and opioid analgesics considered third-line
Scant evidence on which to draw any conclusions on comparative agents (opioids, TCAs, anti-convulsants)
Cochrane Review of Tramadol for Neuropathic Pain 3 RCTs (n=303 ) of tramadol vs. placebo
Duration 4 – 6 wks Tramadol dose = 100 – 400mg/day
Moulin DE, et al. Pain Res Manage 2007;12:13-21.Duehmke RM, et al. CDSR 2009.
Neuropathic PainIntervention 50% Pain
Improvement (NNT)
Withdrawal due to Side Effects
(NNH)Tramadol vs. placebo 3.8 7.7
Duehmke RM, et al. CDSR 2009.Finnerup NB, et al. Pain 2005;118:289-305.
Side Effect Profile Comparisons
Nausea, constipation: tramadol < codeine and morphine
Respiratory depression: Tramadol << morphine, oxycodone
GI bleeding, renal impairment, CV risk: Non-existent with tramadol Increased risk with NSAIDs, especially with risk factors
Smith AB, et al. Am J Surg 2004;187:521-7.Grond S, et al. Clin Pharmacokin 2004;43:879-923.
Other Serious Adverse Events
Serotonin Syndrome Rare with monotherapy Incidence increases with SSRIs, SNRIs, TCAs, etc.
Seizure risk Incidence < 1% (possibly no greater than other
analgesics) May increase 2 - 6-fold with risk factors
EtOH abuse, past stroke or head injury, multiple seizure threshold-reducing drugs, multiple tramadol rx
Increased risk possible with higher doses and concomitant SSRIs, SNRIs, TCAs Gardner JS, et al. Pharmacotherapy 2000;20:1423-
31.Grond S, et al. Clin Pharmacokin 2004;43:879-923.
Abuse Potential
In rat models: Peak brain M1 levels delayed until 20-60 min post-dose As dose increases, brain tramadol:M1 increases
In humans: Negative reports by drug abusers of delay in subjective
CNS effects Tramadol has 1/10 the potency of morphine for analgesia,
but only 1/20 the potency for subjective CNS effects
Raffa RB. J Clin Pharm Therap 2008;33:101-8.
Abuse Potential
Adams, et al. n=11,352 patients with chronic non-cancer pain Positive scoring on Abuse Index within 12 months
NSAIDs = 2.5% Tramadol = 2.7% Hydrocodone = 4.9% (p<0.01)
Ortho-McNeil-funded surveillance program: 454 cases of abuse over 3 yrs 1-3 cases per 100,000 pts
Monitoring program for impaired HCPs (n=1601) 18 cases per 1000 person-yrs
Adams EH, et al. J Pain Symptom Manage 2006;31:465-76.McDiarmid T, et al. J Fam Pract 2005;54:73.
Dollars & CentsMedication Approximate
equivalent dose
~$/30 days
Tramacet (tramadol 37.5mg + acetaminophen 325mg)
2 tabs q4-6h (8/day=300mg) 180
Tramadol long-acting (Ralivia, Tridural, Xytram XL) 300mg OD 100
Celecoxib 200mg BID 90
Naproxen 500mg BID 15
Tylenol #3 (codeine 30mg + acetaminophen 325mg)
2 tabs q4-6h (8/day=240mg) 20
Percocet (oxycodone 5mg + acetaminophen 325mg)
1 tab q6h (4/day=20mg) 15
Morphine SR 15mg q12h 25Amitriptyline 25-100mg 10
To sum up…Acute pain management
Osteoarthritis
Chronic low back pain
Neuropathic pain
Minor side effects (e.g. nausea, constipation, sedation)Serious side effects (e.g. sz, serot synd, resp depression)Abuse potential
Cost
Thank [email protected]